In a preclinical model of nasopharyngeal carcinoma, DC120 significantly reduced tumor volume and CSC in both primary and secondary xenograft tumors, which they attributed to a decrease in SOX2 expression [476]. The gene discussed is SOX2; the disease is neoplasm.